Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Developmental Medicine and Child Neurology|June 1, 1996
Assessment of visuoperceptual disturbance in children with spastic diplegia using measurements of the lateral ventricles on cerebral MRIJ Ito, H Saijo, A Araki, et al.Journal of Radiation Research|January 17, 2002
Dose evaluation based on 24Na activity in the human body at the JCO criticality accident in Tokai-muraT Momose, N Tsujimura, T Tasaki, et al.Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1990
[Long-term follow-up results of TUL (transurethral ureterolithotripsy)]M Hayashi, A Yamasaki, M Noguchi, et al.The Journal of Nutrition|October 1, 1990
Effect of vitamin C depletion on serum cholesterol and lipoprotein levels in ODS (od/od) rats unable to synthesize ascorbic acidK Uchida, Y Nomura, H Takase, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1995
Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibodyA Nakamura, Y Yamamoto, T Tasaki, et al.Developmental Medicine and Child Neurology|June 1, 1997
Neuroradiological assessment of visuoperceptual disturbance in children with spina bifida and hydrocephalusJ Ito, H Saijo, A Araki, et al.Transfusion|April 1, 1994
Iron and erythropoietin measurement in autologous blood donors with anemia: implications for managementT Tasaki, H Ohto, M Noguchi, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1995
Anti-peptide antibodies to the P4502D subfamily in rat, dog and manA Nakamura, Y Yamamoto, T Tasaki, et al.Pharmacogenetics|March 25, 1998
Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2Y Yamamoto, T Tasaki, A Nakamura, et al.The Journal of Toxicological Sciences|June 30, 2001
Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 miceM Torii, F Itoh, K Yabuuchi, et al.Pageof 6